Thurston Springer Miller Herd & Titak’s iShares US Medical Devices ETF IHI Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-232	Closed	-$14.6K	–	940
2025 Q2	$14.6K	Buy	232 +55	+31%	+$3.31K	﹤0.01%	1048
2025 Q1	$10.7K	Sell	177 -4,544	-96%	-$282K	﹤0.01%	1096
2024 Q4	$276K	Buy	4,721 +366	+8%	+$21.8K	0.06%	237
2024 Q3	$258K	Buy	+4,355	New	+$249K	0.07%	222

Other funds holding IHI

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's IHI Position: Q3 2025 in Review

Thurston Springer Miller Herd & Titak sold out of iShares US Medical Devices ETF (IHI) in Q3 2025, closing a stake of 232 shares — an estimated $14.6K sold.

Thurston Springer Miller Herd & Titak first reported a position in IHI in Q3 2024 and held it in 4 quarters. The position peaked at $276K in Q4 2024. 526 funds tracked by Wall St. Rank hold IHI as of Q3 2025.

Thurston Springer Miller Herd & Titak reported no remaining iShares US Medical Devices ETF position as of Q3 2025 after selling out during the quarter.
Thurston Springer Miller Herd & Titak sold 232 iShares US Medical Devices ETF shares in Q3 2025, an estimated $14.6K.
Thurston Springer Miller Herd & Titak first reported a position in iShares US Medical Devices ETF in Q3 2024 and held it in 4 quarters.
Thurston Springer Miller Herd & Titak's iShares US Medical Devices ETF position peaked at $276K in Q4 2024.
526 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2025.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q3 2025, filed 7 Oct 2025.